Mainly because proxy solicitor for CHS.. CHS issues statement in response to Tenet rejection of all-cash offer Community Health Systems, Inc. today issued the following declaration in response to Tenet Healthcare Corporation’s rejection of CHS’s present to acquire all the excellent shares of Tenet for $6.00 per share in cash. Related StoriesAddressing quality of life needs in prostate malignancy: an interview with Professor Louis DenisOJ Bio at Medica 2015 – Point of Care diagnostics' function in reducing antibiotics prescribingGenetic carrier screening: an interview with Don Hardison, CEO of Good Start Genetics’We are disappointed that the Tenet Plank of Directors rejected our all-cash offer and refuses to engage with us.‘If you could directly target the medication to these cells,’ Dhodapkar says, ‘it may be sufficient enough to create a vaccine. The publicity of heat shock proteins on dying cells represents an immunogenic type of cell death. And their results aren’t limited to a single tumor: After treatment with bortezomib, dying lymphoma and breasts cancer cells experienced the same upsurge in hsp90. How well this study will translate to improved survival rates depends upon how applicable these tissue culture research are to the real immune system response in people. Therefore Dhodapkar programs to determine if the enhanced T-cell impact he witnessed in tissue culture holds true in patients treated with this drug.